About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Microbiology research group of the Vall d'Hebron Research Institute (VHIR) focuses on the study of microbiological aspects —in basic, translational and clinical research— that could improve the outcome of patients with infectious diseases.
Our priority research areas are:
We actively collaborate with other microbiology laboratories, health services, national and international centres and organizations, as well as with the different research networks of the Carlos III Health Institute in Spain.
In addition, we carry out an important activity in the surveillance of the genotypic and phenotypic evolution of microorganisms present in the community in terms of their virulence, transmissibility, antigenic escape and antimicrobial resistance, in collaboration with public administrations, both at the national and international level.
PMID: 32020041 Journal: Scientific Reports Year: 2020 Reference: Sci Rep. 2020 Feb 4;10(1):1760. doi: 10.1038/s41598-020-58691-3. Impact factor: 3.998 Publication type: Paper in international publication Authors: Aregall, Nuria, Michl, Kristina, Sabria, Jaume, Rodriguez Garrido, Virginia, Goterris, Lidia, Bosch, Albert, Pinto, Rosa Maria, Guix, Susana, Sabria, Aurora, Vu, Diem-Lan et al. DOI: 10.1038/s41598-020-58691-3
PMID: 31830370 Journal: Small Year: 2020 Reference: Small. 2020 Jan;16(3):e1906108. doi: 10.1002/smll.201906108. Epub 2019 Dec 12. Impact factor: 11.459 Publication type: Paper in international publication Authors: Ferrer, Ricard, Fabrega, Anna, Altug, Hatice, Ruiz-Rodriguez, Juan Carlos, Gonzalez-Lopez, Juan Jose, Yesilkoy, Filiz, Belushkin, Alexander et al. DOI: 10.1002/smll.201906108
PMID: 31955099 Journal: SCIENCE OF THE TOTAL ENVIRONMENT Year: 2020 Reference: Sci Total Environ. 2020 Apr 15;713:136604. doi: 10.1016/j.scitotenv.2020.136604. Epub 2020 Jan 8. Impact factor: 6.551 Publication type: Paper in international publication Authors: Martinez-Puchol, Sandra, Rusinol, Marta, Fernandez-Cassi, Xavier, Timoneda, Natalia, Itarte, Marta, Andres, Cristina, Anton, Andres, Abril, Josep F, Girones, Rosina, Bofill-Mas, Silvia et al. DOI: 10.1016/j.scitotenv.2020.136604
PMID: 31941694 Journal: JOURNAL OF CLINICAL MICROBIOLOGY Year: 2020 Reference: J Clin Microbiol. 2020 Mar 25;58(4). pii: JCM.01886-19. doi: 10.1128/JCM.01886-19. Print 2020 Mar 25. Impact factor: 5.897 Publication type: Paper in international publication Authors: Fernandez-Naval, Candela, Barbera, Maria-Jesus, Aparicio, David, Pich, Oscar Q, Pumarola, Tomas, Jensen, Jorgen S, Espasa, Mateu, Moreno-Mingorance, Albert, Esperalba, Juliana, Serra-Pladevall, Judit et al. DOI: 10.1128/JCM.01886-19
PMID: 30789955 Journal: PLoS One Year: 2019 Reference: PLoS One. 2019 Feb 21;14(2):e0212791. doi: 10.1371/journal.pone.0212791. eCollection 2019. Impact factor: 2.776 Publication type: Paper in international publication Authors: Roure, Silvia, Valerio, Lluis, Soldevila, Laura, Salvador, Fernando, Fernandez-Rivas, Gema, Sulleiro, Elena, Manosa, Miriam, Sopena, Nieves, Mate, Jose Luis, Clotet, Bonaventura et al. DOI: 10.1371/journal.pone.0212791
PMID: 30784235 Journal: PEDIATRIC PULMONOLOGY Year: 2019 Reference: Pediatr Pulmonol. 2019 May;54(5):517-524. doi: 10.1002/ppul.24279. Epub 2019 Feb 19. Impact factor: 2.801 Publication type: Paper in international publication Authors: Izquierdo, Conchita, Campins, Magda, de Sevilla, Mariona F, Gonzalez-Peris, Sebastia, Uriona, Sonia, Martinez-Osorio, Johanna, Sole-Ribalta, Anna, Codina, Gemma, Esteva, Cristina, Planes, Ana Maria et al. DOI: 10.1002/ppul.24279
PMID: 30782267 Journal: Eurosurveillance Year: 2019 Reference: Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1800089. Impact factor: 7.421 Publication type: Paper in international publication Authors: Calvo, Cristina, Anton, Andres, Imaz, Manuel, Aranzamendi, Maitane, Hernandez-Rodriguez, Agueda, Moreno-Docon, Antonio, Rey-Cao, Sonia, Navascues, Ana, Otero, Almudena, Cabrerizo, Maria et al. DOI: 10.2807/1560-7917.ES.2019.24.7.1800089
PMID: 30771526 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2019 Reference: Clin Microbiol Infect. 2019 May;25(5):633.e5-633.e9. doi: 10.1016/j.cmi.2019.02.008. Epub 2019 Feb 14. Impact factor: 6.425 Publication type: Paper in international publication Authors: Garrido, Marta, Frick, Antoinette, Rodrigo, Carlos, Pumarola, Tomas, Carreras, Elena, Mendez, Elida Vazquez, Anton, Andres, Rando, Ariadna, Arevalo, Silvia, Rodo, Carlota et al. DOI: 10.1016/j.cmi.2019.02.008
The collaboration will focus on several key areas of mutual interest in microbiology in particular antimicrobial resistance and stewardship.
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.
